Dummer R - Search Results

1

p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.

Mihic-Probst D, Mnich CD, Oberholzer PA, Seifert B, Sasse B, Moch H, Dummer R. Mihic-Probst D, et al. Among authors: dummer r. Int J Cancer. 2006 May 1;118(9):2262-8. doi: 10.1002/ijc.21608. Int J Cancer. 2006. PMID: 16331607

2

A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring.

Dummer R, Gore ME, Hancock BW, Guillou PJ, Grobben HC, Becker JC, Oskam R, Dieleman JP, Burg G. Dummer R, et al. Cancer. 1995 Feb 15;75(4):1038-44. doi: 10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f. Cancer. 1995. PMID: 7842406 Clinical Trial.

3

Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA.

Rajan GP, Seifert B, Prümmer O, Joller-Jemelka HI, Burg G, Dummer R. Rajan GP, et al. Among authors: dummer r. Arch Dermatol Res. 1996 Aug;288(9):543-8. doi: 10.1007/BF02505252. Arch Dermatol Res. 1996. PMID: 8874750

4

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules.

Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S, Burg G. Yue FY, et al. Among authors: dummer r. Int J Cancer. 1997 May 16;71(4):630-7. doi: 10.1002/(sici)1097-0215(19970516)71:4<630::aid-ijc20>3.0.co;2-e. Int J Cancer. 1997. PMID: 9178819

5

Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.

Wimmer I, Meyer JC, Seifert B, Dummer R, Flace A, Burg G. Wimmer I, et al. Among authors: dummer r. Cancer Res. 1997 Nov 15;57(22):5073-6. Cancer Res. 1997. PMID: 9371505

6

Immune escape mechanisms in malignant melanoma.

Geertsen R, Hofbauer G, Kamarashev J, Yue FY, Dummer R. Geertsen R, et al. Among authors: dummer r. Int J Mol Med. 1999 Jan;3(1):49-57. doi: 10.3892/ijmm.3.1.49. Int J Mol Med. 1999. PMID: 9864385 Review.

7

Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN-gamma in melanoma cell cultures established from CNS lesions.

Geertsen R, Zenklusen R, Kamarashev J, Burg G, Dummer R. Geertsen R, et al. Among authors: dummer r. Int J Cancer. 1999 Sep 24;83(1):135-40. doi: 10.1002/(sici)1097-0215(19990924)83:1<135::aid-ijc23>3.0.co;2-2. Int J Cancer. 1999. PMID: 10449620

8

CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas.

Laetsch B, Häffner AC, Döbbeling U, Seifert B, Ludwig E, Burg G, Dummer R. Laetsch B, et al. Among authors: dummer r. J Invest Dermatol. 2000 Jan;114(1):107-11. doi: 10.1046/j.1523-1747.2000.00818.x. J Invest Dermatol. 2000. PMID: 10620124 Free article.

9

TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.

Kamarashev J, Ferrone S, Seifert B, Böni R, Nestle FO, Burg G, Dummer R. Kamarashev J, et al. Among authors: dummer r. Int J Cancer. 2001 Jan 20;95(1):23-8. doi: 10.1002/1097-0215(20010120)95:1<23::aid-ijc1004>3.0.co;2-4. Int J Cancer. 2001. PMID: 11241306

10

Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

Dummer R, Bösch U, Panizzon R, Bloch PH, Burg G; Task Force 'Skin Cancer'. Swiss National Program against Cancer. Swiss Cancer League. Dummer R, et al. Dermatology. 2001;203(1):75-80. doi: 10.1159/000051710. Dermatology. 2001. PMID: 11549807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,026 results

Search Page

Filters